MyFinsight
Home
Blog
About
Contact
Download
Download image
Derivative warrant
liabilities loss (gain)
-$8,244K
Accrued liabilities
$3,456K
Accounts receivable, net
-$2,302K
Depreciation and
amortization
$885K
Inventory write-down
$835K
Inventories
-$609K
Stock-based compensation
expense
$283K
Other operating
assets and...
-$182K
Amortization of debt discount
and issuance costs
$29K
Net cash provided by
operating activities
$3,675K
Canceled cashflow
$13,150K
Net change in cash
and cash...
-$2,605K
Canceled cashflow
$3,675K
Net (loss) income
-$10,584K
Prepaid expenses and
other current assets
$1,483K
Accounts payable
-$1,083K
Net cash used in
financing activities
-$6,263K
Net cash (used in)
provided by investing...
-$17K
Net proceeds
received from revolving...
-$5,798K
Payments made to
borrowings
$465K
Cash payments for
fixed asset purchases
$17K
Back
Back
Cash Flow
source: myfinsight.com
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)